The findings identify specific receptors for the neurotransmitter acetylcholine that re-route information flowing through memory circuits in the hippocampus.
Bristol-led research has identified specific drug targets within the neural circuits that encode memories, paving the way for significant advances in the treatment of a broad spectrum of brain disorders.
Loss of memory is a core feature of many neurological and psychiatric disorders including Alzheimer’s disease and schizophrenia. Current treatment options for memory loss are very limited and the search for safe and effective drug therapies has, until now, had limited success.
The research was done in collaboration with colleagues at the international biopharmaceutical company Sosei Heptares. The findings, published in Nature Communications, identify specific receptors for the neurotransmitter acetylcholine that re-route information flowing through memory circuits in the hippocampus. Acetylcholine is released in the brain during learning and is critical for the acquisition of new memories. Until now, the only effective treatment for the symptoms of cognitive or memory impairment seen in diseases such as Alzheimer’s is using drugs that broadly boost acetylcholine. However, this leads to multiple adverse side effects. The discovery of specific receptor targets that have the potential to provide the positive effects whilst avoiding the negative ones is promising.
Lead author, Professor Jack Mellor, from the University of Bristol’s Centre for Synaptic Plasticity, said: “These findings are about the fundamental processes that occur in the brain during the encoding of memory and how they may be regulated by brain state or drugs targeting specific receptor proteins. In the long-term, the discovery of these specific targets opens up avenues and opportunities for the development of new treatments for the symptoms of Alzheimer’s disease and other conditions with prominent cognitive impairments. The academic-industry partnership is important for these discoveries and we hope to continue working together on these projects.”
Dr Miles Congreve, Chief Scientific Officer at Sosei Heptares, added: “These important studies have helped us to design and select new, exquisitely targeted therapeutic agents that mimic the effects of acetylcholine at specific muscarinic receptors, without triggering the unwanted side effects of earlier and less-well targeted treatments. This approach has the exciting potential to improve memory and cognitive function in patients with Alzheimer’s and other neurological diseases.”
“It is fascinating how the brain prioritises different bits of information, working out what is important to encode in memory and what can be discarded. We know there must be mechanisms to pull out the things that are important to us but we know very little about how these processes work. Our future programme of work aims to reveal how the brain does this using acetylcholine in tandem with other neurotransmitters such as dopamine, serotonin and noradrenaline,” said Professor Mellor.
Original Article: Research reveals drug targets for memory enhancement
More from: University of Bristol
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Memory loss treatment
- Memory & Company Secures FirePower Capital Boost to Expand Unforgettable Careon May 9, 2024 at 8:30 am
Memory & Company provides the VIP treatment for people living with Memory loss, and provides a guilt-free respite options for their Care Partners by offering a Premium Day Program, along with ...
- Getting Alzheimer’s treatment to those who need it poses particular challengeson May 9, 2024 at 1:31 am
Diagnosis, treatment, monitoring and access can pose problems for both patients and their doctors, experts said at a STAT virtual event Wednesday.
- Robert F. Kennedy Jr.: Worm ate part of brain, then died in head, caused memory loss, fogginesson May 8, 2024 at 10:59 am
What many doctors thought was a brain tumor Robert F. Kennedy Jr. was suffering from back in 2010, a doctor at NewYork-Presbyterian Hospital believed was a dead parasite in his head. Kennedy revealed ...
- Presidential candidate Kennedy says worm entered his brain, caused temporary memory loss, brain fogon May 8, 2024 at 10:35 am
Kennedy’s campaign says candidate “traveled extensively in Africa, South America and Asia” as environmental advocate, contracted a parasite on one trip ...
- RFK Jr. says he had parasitic brain worm and undisclosed memory losson May 8, 2024 at 9:10 am
Kennedy’s campaign spokeswoman said he contracted a parasite years ago while traveling “extensively in Africa, South America and Asia in his work as an environmental advocate.” ...
Go deeper with Google Headlines on:
Memory loss treatment
[google_news title=”” keyword=”memory loss treatment” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Acetylcholine
- Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Resultson May 9, 2024 at 9:01 am
Phase 2 MaGic gMG trial initiated in February: The MaGic trial is a global, randomized, double-blind, placebo-controlled Phase 2 study in up to 60 patients with gMG who are acetylcholine receptor ...
- Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating Effects of NBI-1076986 in Healthy Adultson May 9, 2024 at 5:30 am
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the initiation of its Phase 1 first-in-human clinical study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of ...
- Four hacks to avoid car travel sickness ahead of summer road trips – eating a £2.35 treat* can work wonderson May 9, 2024 at 2:14 am
TRAVEL sickness is a major problem faced by drivers and passengers alike on long road trips. Nearly half of road users across the world are affected, according to one study from the Ford Research ...
- Everything You Need To Know About Cholineon May 8, 2024 at 12:00 pm
Medically reviewed by Aviv Joshua, MS Choline is an essential nutrient often grouped with the B vitamins due to its similar functions in the body. While it is classified as a chemical compound rather ...
- Dr. Oz discusses the rewards of relaxingon May 8, 2024 at 1:15 am
This happens because stress hormones are reduced and acetylcholine, the chief neurotransmitter in your parasympathetic nervous system, is released, relaxing blood vessels. Inflammation also is tamped ...
Go deeper with Google Headlines on:
Acetylcholine
[google_news title=”” keyword=”acetylcholine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]